Back to User profile » Dr Mark Bergmann

Papers published by Dr Mark Bergmann:

Clinical Trial Report

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

Sheppard J, Bergmann M, Schechter BA, Luchs J, Ogundele A, Karpecki P

Clinical Ophthalmology 2021, 15:129-140

Published Date: 12 January 2021

Original Research

Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis

McLaurin E, Bergmann M, Narvekar A, Adewale A, Gomes P, Torkildsen G

Clinical Ophthalmology 2017, 11:1089-1097

Published Date: 8 June 2017

Original Research

Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model

Torkildsen G, Narvekar A, Bergmann M

Clinical Ophthalmology 2015, 9:1703-1713

Published Date: 14 September 2015

Original Research

Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%

Bergmann MT, Williams JI, Gomes PJ

Clinical Ophthalmology 2014, 8:1495-1505

Published Date: 13 August 2014